LTRN: First Quarter 2022 Financial and Operational Results
By John Vandermosten, CFA
NASDAQ:LTRN
READ THE FULL LTRN RESEARCH REPORT
Benzinga ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
The Latest Breaking News from LTRN
Recap: Lantern Pharma Q1 Earnings
Lantern Pharma (NASDAQ:LTRN) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Lantern Pharma missed estimated earnings by 31.03%, reporting an EPS of $-0.38 versus an estimate of $-0.29.
Benzinga ·
LTRN: Multiple Collaborations Illuminating Way Forward
By John Vandermosten, CFA
NASDAQ:LTRN
READ THE FULL LTRN RESEARCH REPORT
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
People
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
